Literature DB >> 8413328

The interaction between different domains of staphylococcal protein A and human polyclonal IgG, IgA, IgM and F(ab')2: separation of affinity from specificity.

U K Ljungberg1, B Jansson, U Niss, R Nilsson, B E Sandberg, B Nilsson.   

Abstract

Binding properties of staphylococcal protein A (SpA) to different human immunoglobulins have been investigated. In this analysis, intact SpA as well as SpA-derived fragments containing one to five IgG-binding domains of different compositions, were used. The affinity binding constants of the different proteins to human polyclonal IgG, IgA, IgM and F(ab')2-fragments as well as their binding capacity to the immunoglobulin molecules were determined. The results show that although all the proteins bound to IgG, regardless of size or composition, the binding strength differed significantly. Proteins containing five domains have a stronger affinity for IgG than those containing one or two. There were no marked differences in binding strength between different domains. However, the binding ability to IgA and IgM showed a marked difference between the various SpA-derived proteins of different compositions. This discrepancy was correlated to differences in their relative binding properties to isolated F(ab')2-fragments of IgG. Hence, we conclude that the binding affinity is mainly affected by the number of domains, whereas the binding specificity is to a large extent determined by which domains are selected.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8413328     DOI: 10.1016/0161-5890(93)90044-c

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  23 in total

1.  Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles.

Authors:  Vladimir P Zharov; Kelly E Mercer; Elena N Galitovskaya; Mark S Smeltzer
Journal:  Biophys J       Date:  2005-10-20       Impact factor: 4.033

2.  A study of the interactions between an IgG-binding domain based on the B domain of staphylococcal protein A and rabbit IgG.

Authors:  N L Brown; S P Bottomley; M D Scawen; M G Gore
Journal:  Mol Biotechnol       Date:  1998-08       Impact factor: 2.695

3.  Improved Protein-A separation of V(H)3 Fab from Fc after papain digestion of antibodies.

Authors:  Therese A Seldon; Karen E Hughes; David J Munster; David Y Chin; Martina L Jones
Journal:  J Biomol Tech       Date:  2011-07

4.  Variable region structure and staphylococcal protein A binding specificity of a mouse monoclonal IgM anti-laminin-receptor antibody.

Authors:  G C Feijó; J Sabbaga; C R Carneiro; M M Brígido
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

5.  Affinity proteomics to study endogenous protein complexes: pointers, pitfalls, preferences and perspectives.

Authors:  John LaCava; Kelly R Molloy; Martin S Taylor; Michal Domanski; Brian T Chait; Michael P Rout
Journal:  Biotechniques       Date:  2015-03-01       Impact factor: 1.993

6.  Tricomponent immunopotentiating system as a novel molecular design strategy for malaria vaccine development.

Authors:  Takeshi Miyata; Tetsuya Harakuni; Takafumi Tsuboi; Jetsumon Sattabongkot; Ayumu Ikehara; Mayumi Tachibana; Motomi Torii; Goro Matsuzaki; Takeshi Arakawa
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

7.  Engineered high-affinity nanobodies recognizing staphylococcal Protein A and suitable for native isolation of protein complexes.

Authors:  Peter C Fridy; Mary K Thompson; Natalia E Ketaren; Michael P Rout
Journal:  Anal Biochem       Date:  2015-02-21       Impact factor: 3.365

8.  Improved native isolation of endogenous Protein A-tagged protein complexes.

Authors:  John LaCava; Nagarajan Chandramouli; Hua Jiang; Michael P Rout
Journal:  Biotechniques       Date:  2013-04       Impact factor: 1.993

9.  Cysteine-terminated B-domain of Staphylococcus aureus protein A as a scaffold for targeting GABA(A) receptors.

Authors:  Nasser M Qtaishat; Hélène A Gussin; David R Pepperberg
Journal:  Anal Biochem       Date:  2012-09-19       Impact factor: 3.365

10.  A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes.

Authors:  Bo Zhang; Rajiv B Kumar; Hongjie Dai; Brian J Feldman
Journal:  Nat Med       Date:  2014-07-13       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.